Clinical trial
Yellow Fever Virus Vaccine and Immune Globulin Study
NCT00254826 · Emory University, Other · Completed
Key facts
| NCT number | NCT00254826 |
|---|---|
| Title | Yellow Fever Virus Vaccine and Immune Globulin Study |
| Official title | Randomized Controlled Double-Blind Trial of the Comparative Viremia, Immunogenicity and Safety of a 17-D Live Attenuated Yellow Fever Vaccine (YF-VAX)Given Alone or in Combination With Human Immune Globulin (Gama STAN S/D) |
| Lead sponsor | Emory University, Other |
| Collaborators | Sanofi Pasteur, a Sanofi Company Industry Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Viremia |
| Intervention type | Biological |
| Interventions | YF-VAX® plus saline, 17D YF Vaccine plus Ig |
| Enrollment | 80 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Nov 17, 2005 |
| Last update posted | Dec 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: